Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 4 Takayasu Arteritis 1 Spondylitis, Ankylosing 1 Infections 1 Hematologic Neoplasms 1 Cytokine Release Syndrome 1 Autoimmune Diseases 1 Arthritis 1

Interventions

Etanercept 2 golimumab 1 Tumor Necrosis Factors 1 Sulfasalazine 1 Sodium Chloride 1 Pamidronate 1 Meloxicam 1 Infliximab 1 Etoricoxib 1 Celecoxib 1 Anti-Inflammatory Agents, Non-Steroidal 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Spondylitis, Ankylosing × Infliximab × Clear all

NCT05379049 2022-05-18

TNF-alpha

University of Sulaimani

Arthritis, Arthritis, Rheumatoid, Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡